Zepp Health CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Millennium Management and affiliated entities have filed a Schedule 13G amendment, reporting no beneficial ownership of Zepp Health Corporation's Class A Ordinary Shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed beneficial ownership of 8.5% of Zepp Health Corp's Class A Common Stock as of June 30, 2026.
NYSE
Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has reported beneficial ownership of 10.0% of Zepp Health Corp's Class A Common Stock as of March 31, 2026.
NYSE
FIL Limited and its affiliates have reported a significant 8.7% beneficial ownership stake in Zepp Health Corp's Class A Common Stock as of December 31, 2025.
NYSE
Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, has disclosed a 7.6% beneficial ownership stake in Zepp Health Corp.
NYSE
Millennium Management LLC and its affiliates have disclosed beneficial ownership of 5.8% of Zepp Health Corporation's Class A Ordinary Shares.
NYSE
Allspring Global Investments Holdings, LLC has reported a 2.9% beneficial ownership stake in Zepp Health Corp's Depositary Receipt ADRs.
NYSE
FIL Limited and its affiliates have filed an amended Schedule 13G, reporting no beneficial ownership in ZEPP Health Corp's Class A Common Stock as of July 31, 2025.
NYSE
Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen have jointly disclosed a beneficial ownership of 5.7% in Zepp Health Corp's Class A Ordinary Shares.
NYSE
Allspring Global Investments Holdings, LLC has filed an Amendment No. 7 to its Schedule 13G, reporting a beneficial ownership of 8.7% in Zepp Health Corp's Depositary Receipt ADRs as of June 30, 2025.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed a combined beneficial ownership of 10.2% in Zepp Health Corp's Class A Common Stock as of April 30, 2025.
NYSE
Allspring Global Investments Holdings, LLC has reported a significant beneficial ownership stake of 11.1% in Zepp Health Corp, holding over 13.6 million Depositary Receipt ADRs.